37 related articles for article (PubMed ID: 22619488)
1. HSP110 improves the anti-tumor effects of the cytotoxic T lymphocyte epitope E749-57 in mice: HSP110 as a peptide specific chaperone or adjuvant?
Kalos M
Cancer Biol Ther; 2010 Feb; 9(4):333-4. PubMed ID: 20150756
[No Abstract] [Full Text] [Related]
2. Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity.
Shi W; Bu P; Liu J; Polack A; Fisher S; Qiao L
J Virol; 1999 Sep; 73(9):7877-81. PubMed ID: 10438884
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of human papilloma vaccines in cervical cancer.
Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Evans AS; Mason M
Adv Exp Med Biol; 2001; 495():419-27. PubMed ID: 11774604
[No Abstract] [Full Text] [Related]
4. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.
Liu DW; Tsao YP; Kung JT; Ding YA; Sytwu HK; Xiao X; Chen SL
J Virol; 2000 Mar; 74(6):2888-94. PubMed ID: 10684306
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes and vaccine development 2011.
Xiao Z; Klonowski K; Yang H; Curtsinger J
J Biomed Biotechnol; 2011; 2011():756864. PubMed ID: 22619488
[No Abstract] [Full Text] [Related]
6. Carbohydrate-based vaccines: challenges and opportunities.
Huang YL; Wu CY
Expert Rev Vaccines; 2010 Nov; 9(11):1257-74. PubMed ID: 21087106
[TBL] [Abstract][Full Text] [Related]
7. Antiviral cytotoxic T lymphocyte induction and vaccination.
Rouse BT; Norley S; Martin S
Rev Infect Dis; 1988; 10(1):16-33. PubMed ID: 2451265
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach.
Bharadwaj M; Moss DJ
Expert Rev Vaccines; 2002 Dec; 1(4):467-76. PubMed ID: 12901585
[TBL] [Abstract][Full Text] [Related]
9. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
[TBL] [Abstract][Full Text] [Related]
10. Methods to measure T-cell responses.
Plebanski M; Katsara M; Sheng KC; Xiang SD; Apostolopoulos V
Expert Rev Vaccines; 2010 Jun; 9(6):595-600. PubMed ID: 20518715
[TBL] [Abstract][Full Text] [Related]
11. Viral vaccines and CTL response.
Woolard SN; Kumaraguru U
J Biomed Biotechnol; 2010; 2010():141657. PubMed ID: 20379365
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
